| Ticker | RXDX |
|---|---|
| ISIN | US74349U1088 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated interstitial lung disease. The company also dev...
El precio actual de Prometheus Biosciences, Inc. (RXDX) es de 199,92 , con una variación del 0,09%.
Prometheus Biosciences, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones